TBX1 and lung carcinoma: Silencing of brachyury expression significantly diminished migratory, invasive and metastatic ability in endogenously positive lung cancer cells in vitro (8, 11), which suggests brachyury can be developed into a potential therapeutic target in anti-tumor treatment of lung cancer.